Asthma Resources for Healthcare Professionals
Long-term management of asthma requires a stepwise approach to pharmacotherapy with regular monitoring and follow-up.1 In cases of persistent asthma, daily long-term control medications are needed in order to achieve and maintain control. The most effective asthma control medications are those that treat the underlying inflammation associated with asthma,1 such as QVAR®. Chronic inflammation, if left untreated, can cause remodeling of the small airways of the lungs.2,3
To help you provide your patients with the best asthma care possible, we have put together the following resources:
QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age or older. QVAR® is also indicated for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.
Important Safety Information
CAUTION: Adrenal insufficiency may occur when transferring patients from systemic steroids (see WARNINGS, Prescribing Information).
- QVAR® is not a bronchodilator and is not indicated for relief of acute bronchospasm.
- A reduction in growth velocity in growing children and teenagers may occur as a result of inadequate control of chronic diseases such as asthma or from use of corticosteroids for treatment
- Common side effects associated with the use of QVAR® and placebo in clinical trials include, but are not limited to, headache (12% and 9% respectively) and pharyngitis (8% and 4% respectively).